Impact of Age and Autoantibody Status on the Gene Expression of Scleroderma Fibroblasts in Response to Silica Stimulation

Impact of Age and Autoantibody Status on the Gene Expression of Scleroderma Fibroblasts in Response to Silica Stimulation

Environmental factors are believed to play an important role in the pathogenesis of systemic sclerosis (SSc). Silica exposure has been implicated as potentially hazardous in epidemiological studies of SSc. It can activate fibroblasts to express profibrotic genes at certain conditions. The aim of thi...

Full description

Bibliographic Details
Main Authors:	Y. Yang, P. Wei, X.J. Guo, D. Zhou, W.Z. Zhang, S. Assassi, X.D. Zhou
Format:	Article
Language:	English
Published:	SAGE Publishing 2013-09-01
Series:	European Journal of Inflammation
Online Access:	https://doi.org/10.1177/1721727X1301100307

Similar Items

Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
by: Elena Raschi, et al.
Published: (2018-08-01)

Genetics of scleroderma: implications for personalized medicine?
by: Assassi Shervin, et al.
Published: (2013-01-01)

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
by: Campochiaro, C., et al.
Published: (2022)

Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
by: Zoe E. Betteridge, et al.
Published: (2018-08-01)

Differential modulation of fibroblast properties in scleroderma
by: Xu, Shi-Wen
Published: (1998)

Endothelial cell-fibroblast interactions in scleroderma
by: Denton, Christopher Paul
Published: (1997)

Differential dynamic properties of scleroderma fibroblasts in response to perturbation of environmental stimuli.
by: Momiao Xiong, et al.
Published: (2008-02-01)

Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.
by: Richard A Steinman, et al.
Published: (2012-01-01)

CD47 prevents the elimination of diseased fibroblasts in scleroderma
by: Tristan Lerbs, et al.
Published: (2020-08-01)

Biomarkers in scleroderma: Current status
by: Latika Gupta, et al.
Published: (2017-01-01)

Association of the HLA-DRB1 with scleroderma in Chinese population.
by: Dongyi He, et al.
Published: (2014-01-01)

Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016-11-01)

Scleroderma of geriatric age and scleroderma-like paraneoplastic syndrome – description of two cases
by: Magdalena Marek, et al.
Published: (2016-06-01)

Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice
by: Yinghua Song, et al.
Published: (2013-10-01)

Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
by: Elena Raschi, et al.
Published: (2020-11-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
by: N. A. Shostak, et al.
Published: (2020-05-01)

PARANEOPLASTIC SCLERODERMA OR NEOPLASIA SECONDARY TO SCLERODERMA
by: Alexandru Arvunescu, et al.
Published: (2019-12-01)

Mimics of scleroderma
by: Kaveri K Nalianda, et al.
Published: (2017-01-01)

Study on the pathological effects of scleroderma-associated autoantibodies, anti-CENP B and anti-TOPO 1, on vascular endothelial cells
by: Pei-Hsuan Lai, et al.
Published: (2011)

Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
by: S. Soldano, et al.
Published: (2011-01-01)

Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration
by: Bahja Ahmed Abdi, et al.
Published: (2017-06-01)

Bioinformatics analysis of biomarkers and transcriptional factor motifs in Down syndrome
by: X.D. Kong, et al.
Published: (2014-10-01)

Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3
by: Andreas Recke, et al.
Published: (2018-03-01)

Keloids in scleroderma-keloidal scleroderma: A unique entity
by: Sumit Sen, et al.
Published: (2013-01-01)

Psychosocial Status in Turkish Scleroderma Patients: Hopelessness and Social Support
Published: (2016-01-01)

SCLERODERMA IN PEDIATRIC AGE GROUP: REPORT OF 25 CASES
by: M.H.Moradi-Nejad
Published: (1999-06-01)

SCLERODERMA IN PEDIATRIC AGE GROUP: REPORT OF 25 CASES
by: M.H.Moradi-Nejad
Published: (1999-07-01)

The transcriptional cofactor nab2 is induced by tgf-Beta and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma.
by: Swati Bhattacharyya, et al.
Published: (2009-10-01)

The pathogenesis of scleroderma
by: Latika Gupta, et al.
Published: (2017-01-01)

Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts
by: Maurizio Cutolo, et al.
Published: (2018-05-01)

The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects
by: Galina S. Bogatkevich, et al.
Published: (2012-01-01)

Fibrosing arthropathy in juvenile scleroderma
by: D. A. Dibrov, et al.
Published: (2021-04-01)

Scleroderma-panniculitis: view of the rheumatologist
by: A. S. Potapova, et al.
Published: (2021-04-01)

THE CASE OF THE DEBUT OF SYSTEMIC SCLERODERMA IN A PATIENT AGED 10
by: А. V. BURLUTSKAYA, et al.
Published: (2018-07-01)

Stimulation of wound healing using bioinspired hydrogels with basic fibroblast growth factor (bFGF)
by: Zhang X, et al.
Published: (2018-07-01)

Vascular involvement in systemic sclerosis (scleroderma)
by: Pattanaik D, et al.
Published: (2011-07-01)

Treatment for systemic scleroderma
by: Rezvaya Tairovich Alekperov, et al.
Published: (2011-09-01)

Purtscher’s retinopathy in scleroderma
by: Alzahrani, Mazen, et al.
Published: (2019-03-01)

Finger Printlessness in Scleroderma
by: Milad HOSSEINIALHASHEMI, et al.
Published: (2016-08-01)

Scleroderma renal crisis
by: Gioacchino Li Cavoli, et al.
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_dm32jr6crd7li0vgu97vqnge3g